Explore ViiV Healthcare

I am a
  • HCP
  • person living with HIV
  • NGO or patient group
  • job seeker
  • member of the public
  • academia / entrepreneur
  • media
...looking for
  • information about VHC medicines
  • clinical data and insights on VHC medicines
  • Independent Medical Education
  • medicines in development
  • how VHC is advancing HIV treatment and care
...looking for
  • information about VHC medicines
  • information and support about living with HIV
  • how to report a side effect
  • news and stories from ViiV Healthcare
...looking for
  • funding / grants
  • ViiV Healthcare's approach to partnerships
  • how ViiV Healthcare works with NGOs
  • news and stories from ViiV Healthcare
  • connect with ViiV Healthcare's community
...looking for
  • job opportunities
  • information about ViiV Healthcare
  • ViiV Healthcare's office locations
  • news and stories from ViiV Healthcare
...looking for
  • who are ViiV Healthcare
  • corporate ethics & compliance
  • news and stories from ViiV Healthcare
...looking for
  • opportunities to partner with ViiV Healthcare
  • information on ViiV Healthcare's Innovation Unit
  • news and stories from ViiV Healthcare
...looking for
  • press releases
  • ViiV Healthcare's Leadership
  • news and stories from ViiV Healthcare

ViiV Healthcare ranks #1 in PatientView corporate reputation survey

Thank you to all the organizations that recognised our commitment to patients. We continue to be 100% focussed on people living with HIV.

ViiV Healthcare is extremely proud to be the highest-ranked company in the PatientView ‘Corporate Reputation of Pharma – from the Perspective of Patient Groups’ report for the fourth year running, having this year achieved top scores across all seven of the evaluation indicators.

This recognition is testament to ViiV Healthcare’s strong focus and commitment to people living with HIV and the way we work in partnership with patient groups to play our part in responding to the HIV epidemic.

Company Final Rank Average score across 7 indicators
ViiV Healthcare 1 47.5%
AbbVie 2 35.3%
Novartis 3 26.0%
Novo Nordisk 4 25.4%
Gilead Sciences 5 26.1%
Grifols 6 24.1%
Janssen 7 23.4%
Roche 8 22.0%
Lundbeck 8 21.7%
Shire 10 22.2%
UCB 11 20.7%